{
	"kj8tvt9fText": "Bri<span class=\"_ _0\"></span>nte<span class=\"_ _0\"></span>lli<span class=\"_ _0\"></span>x® i<span class=\"_ _0\"></span>mpr<span class=\"_ _0\"></span>o<span class=\"_ _0\"></span>v<span class=\"_ _0\"></span>es fun<span class=\"_ _0\"></span>c<span class=\"_ _1\"></span>tion<span class=\"_ _0\"></span>al cap<span class=\"_ _0\"></span>ac<span class=\"_ _0\"></span>it<span class=\"_ _1\"></span>y in MD<span class=\"_ _0\"></span>D <br><span class=\"ls11 ws21\">patient<span class=\"_ _1\"></span>s<span class=\"_ _0\"></span>*<span class=\"fs2 ls12 ws22 v1\">1,2</span></span>",
	"kj8tvt9gText": "UPSA",
	"kj8tvt9hText": "Study Design",
	"kj8tvt9iText": "No significant ",
	"kj8tvt9jText": " differ<span class=\"_ _0\"></span>ence <span class=\"_ _16\"> </span>was ",
	"kj8tvt9kText": " observed <span class=\"_ _16\"> </span>between ",
	"kj8tvt9lText": " duloxetine <span class=\"_ _16\"> </span>and ",
	"kj8tvt9mText": " placebo<span class=\"fs11 v4\">1</span>",
	"kj8tvt9nText": "Brintel<span class=\"_ _0\"></span>lix® is the only a<span class=\"_ _0\"></span>ntidepressant to h<span class=\"_ _0\"></span>av<span class=\"_ _0\"></span>e demonstrated ef<span class=\"_ _1\"></span>ficacy in <br><span class=\"ls14 ws27\">improving patient<span class=\"_ _1\"></span>s’ abilities to<span class=\"_ _1\"></span>  <span class=\"_ _11\"></span>perform<span class=\"_ _1\"></span> daily task<span class=\"_ _1\"></span>s<span class=\"_ _0\"></span>*<span class=\"fs12 ls0 v5\">1</span></span>",
	"kj8tvt9zText": "SDS<span class=\"_\"> </span><span class=\"ff1 fc3 ws24\">UPSA<span class=\"_\"> </span></span>Summary",
	"Brintellix_322f678208": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; line-height: 1; color: rgb(84, 122, 129); display: block;text-align: center;\">\n<font style=\"font-size: 20px;\">\nBrintellix<sup>®</sup> demonstrates superiority to placebo in improvement of<br>fuctional capacity as shown by UPSA<sup>1</sup>\n</font>\n</span>",
	"Brintellix_3202ed8c4e": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; line-height: 1.2; color: rgb(84, 122, 129); display: block;text-align: center;\">\n<font style=\"font-size: 16px;\">\nMean change from baseline in UPSA composite score\n</font>\n</span>",
	"Brintellix_327418d2ca": "<p style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; color: rgb(100, 94, 94); line-height: 1.23; display: block;\">\n<font style=\"font-size: 11.5px;\">\n\t*As measured by UPSA; **p&lt;0.001 vs. placebo. <br style=\"\">\n\t<span style=\"display: inline-block;padding-top: 10px;\">From an eight-week, randomised, double-blind, placebo-controlled study designed to assess the efficacy of Brintellix<sup style=\"\">®</sup> on aspects of cognitive performance in adult patients with MDD. Duloxetine was included as an active reference for study validation, not for comparison of effect sizes. University of California San Diego Performance-Based Skills Assessment-brief version (UPSA, functional capacity). University of California San Diego Performance-Based Skills Assessment (UPSA) composite score is a combination of UPSA and UPSA-brief.</span><br>\n\t<span style=\"display: inline-block;padding-top: 10px;\">N numbers relate to the patient populations who completed this study.</span>\n</font>\n</p>",
	"Brintellix_32d5fcdc7a": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; line-height: 1; color: rgb(84, 122, 129); display: block;text-align: center;\">\n<font style=\"font-size: 22.5px;\"><div style=\"text-align: left;\">The University of San Diego Performance-Based Skills Assessment (UPSA)<sup>1</sup></div></font></span>",
	"Brintellix_32535afca6": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(100, 94, 94); line-height: 1.2;display:block;\">\n<font style=\"font-size: 17.5px;\">\n\tThe University of San Diego Performance-Based Skills Assessment (UPSA) is a measure of<br>\n\teveryday functional capacity designed to assess skills, such as the ability to plan and organise,<br>\n\tthat are important components of independent living\n</font>\n</span>",
	"Brintellix_3254bc7bd9": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: #f28700; \">\n<font style=\"font-size: 17px;\">HOUSEHOLD CHORES</font>\n</span>",
	"Brintellix_3211b15f53": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: #f28700; \">\n<font style=\"font-size: 17px;\">FINANCE</font>\n</span>",
	"Brintellix_32753ffbf9": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: #f28700; \">\n<font style=\"font-size: 17px;\">TRANSPORTATION</font>\n</span>",
	"Brintellix_32e3ce38e5": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: #f28700; \"><div style=\"text-align: center;\"><span style=\"font-size: 17px;\">PLANNING</span></div>\n<font style=\"font-size: 17px;\"><div style=\"text-align: center;\">RECREATIONAL ACTIVITY</div></font></span>",
	"Brintellix_322524a63f": "<span style=\"font-family: &quot;1_CWOXIJ+AvenirNextLTPro-Bold&quot;; color: #f28700; \"><div style=\"text-align: center;\"><span style=\"font-size: 17px;\">COMMUNICATION</span></div></span>",
	"Brintellix_322dd1c544": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; color: rgb(100, 94, 94); line-height:1;\">\n<font style=\"font-size: 11.5px;\"><b>1.</b> Patterson TL et al. Schizophrenia Bull 2001;27:235-245. \n</font>\n</span>",
	"Brintellix_3291b931d7": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_3275957af0": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>1.</b> Mahableshwarkar AR et al. Neuropsychopharmacol 2015;40:2025-2037.\n<br>\n</font>\n</span>",
	"Brintellix_3208ce5783": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\"><font style=\"font-size: 15px;\"><b>2.</b> Brintellix® Summary of Product Characteristics. 2021.\n<br>\n</font>\n</span>",
	"Brintellix_32b71cf520": "Text",
	"Brintellix_32a6fd77fc": "Text",
	"Brintellix_32a42814ef": "Text",
	"Brintellix_32c5659249": "Text",
	"Brintellix_32c0c4c326": "Text",
	"Brintellix_321d0a1f99": "Text",
	"Brintellix_324a9ad97f": "Text",
	"Brintellix_3265f18ecb": "Text",
	"Brintellix_32849b7e3f": "Text",
	"Brintellix_321cb85823": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;color: #4d7f86;\">Cognitive Symptoms&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <span style=\"color: #fff;\">Functionality</span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Motivation &amp; Energy&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Goal Attainment</div>"
}
